...
首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Three photobiomodulation protocols in the prevention/treatment of radiotherapy-induced oral mucositis
【24h】

Three photobiomodulation protocols in the prevention/treatment of radiotherapy-induced oral mucositis

机译:放射疗法诱导口腔粘膜炎预防/治疗的三种光致调节方案

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To compare three Photobiomodulation protocols to prevent/treat oral mucositis associated to radiotherapy.Methods: Seventy-three patients with cancer in oral cavity, oropharynx, and nasopharynx, who underwent RT with dose in facial fields equal or higher than 6000 cGy were randomized into three groups (mean RT dose = 66 cGy +/- 4.9).Protocols of Group 1 was 660 nm, 15 mW, 3.8 J/cm2, Group 2 660 nm, 25 mW, 6.3 J/cm2 both starting on the first day of radiotherapy, and group 3 660 nm, 15 mW, 3.8 J/cm2 for therapeutic purpose. The patients of group 1 and 2 were irradiated at 40 points daily covering non-keratinizing oral mucosa. The spot size (probe's tip surface size) was 0.040 cm2 for all groups. Oral mucositis was evaluated according to both WHO and NCI scales, and pain related to oral mucositis was scored using the VAS.Results: Patients from group 1 presented with grade II oral mucositis later than groups 2 and 3 (p 0.001). Moreover, groups 2 and 3 also presented with a mean higher of oral mucositis grade than group 1, p 0.001. Pain scores were lower in group 1 (p = 0.002).Conclusions: The Photobiomodulation used in Group 1 was more effective than the protocols used in groups 2 and 3 in controlling the grade II oral mucositis intensity, and mean pain scores.
机译:目的:比较三种光生成方案,以防止与放射疗法相关的口腔粘液炎。方法:口腔腔内的七十三名癌症患者,oropharynx和鼻咽癌,在等于或高于6000cy的面部场中的剂量进行鼻咽癌分为三组(意指RT剂量= 66cGy +/- 4.9)。第1组的协议为660nm,15mW,3.8J / cm2,第2组660nm,25 mw,6.3 j / cm2从第一天开始放射疗法,3660nm,15 mW,3.8 j / cm2的治疗用途。第1族和第2组的患者每天覆盖40分覆盖非角质化口腔粘膜。对于所有组的光斑尺寸(探针的尖端表面尺寸)为0.040cm 2。根据WHO和NCI鳞片评估口腔粘膜炎,使用VASults评分与口腔粘液炎相关的疼痛:来自第1组的患者,患有二级口服粘膜肌炎,而不是组2和3(P <0.001)。此外,第2组和3也呈现出比1,P <0.001的口腔粘膜等级的平均值。第1组疼痛分数较低(P = 0.002)。结论:第1组中使用的光生物调节比在控制II级口服粘膜强度和平均疼痛评分中的组2和3中使用的方案更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号